LEADER 01162nam0-2200373li-450 001 990000249750203316 005 20180312154818.0 010 $a88-08-09981-4 035 $a0024975 035 $aUSA010024975 035 $a(ALEPH)000024975USA01 035 $a0024975 100 $a2001999011999-------y0itay0103----ba 101 0 $aita 102 $aIT 200 1 $aElementi di chimica analitica$fDaniel C. Harris$g[traduzione di Nanda Sabbatini] 210 $aBologna$cZanichelli$dcopyr. 1999 215 $aXIV, 495 p.$cill.$d27 cm 312 $aTrad. di: exploring chemical analysis 610 1 $achimica analitica 676 $a543$9Chimica analitica 700 1$aHarris,$bDaniel C.$062995 801 $aSistema bibliotecario di Ateneo dell' Università di Salerno$gRICA 912 $a990000249750203316 951 $a543 HAR$b24583/CBS$c543$d00222366 959 $aBK 969 $aSCI 979 $c19990112 979 $c20001110$lUSA01$h1715 979 $c20020403$lUSA01$h1633 979 $aPATRY$b90$c20040406$lUSA01$h1618 979 $aRSIAV6$b90$c20090703$lUSA01$h1258 996 $aElementi di chimica analitica$9397223 997 $aUNISA LEADER 00716nam0-22002651i-450 001 990001711890403321 005 20201204130417.0 035 $a000171189 035 $aFED01000171189 035 $a(Aleph)000171189FED01 035 $a000171189 100 $a20030910d1979----km-y0itay50------ba 101 0 $aita 200 1 $aElementi di malattie parassitarie. 210 $aMilano$cCLESAV$d1979 215 $a149 p. cicl.$d25 cm 610 0 $aParassitosi veterinaria 676 $a636.089 696 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001711890403321 952 $a60 636.0896 B 25$b48081$fFAGBC 959 $aFAGBC 996 $aELEMENTI di malattie parassitarie$9359641 997 $aUNINA LEADER 03055oam 2200673I 450 001 9910973505503321 005 20251117092021.0 010 $a1-136-33906-X 010 $a1-283-64273-5 010 $a0-203-12342-5 010 $a1-136-33907-8 024 7 $a10.4324/9780203123423 035 $a(CKB)2670000000259330 035 $a(EBL)1039247 035 $a(OCoLC)813843940 035 $a(SSID)ssj0000757882 035 $a(PQKBManifestationID)11486952 035 $a(PQKBTitleCode)TC0000757882 035 $a(PQKBWorkID)10771863 035 $a(PQKB)10076528 035 $a(MiAaPQ)EBC1039247 035 $a(Au-PeEL)EBL1039247 035 $a(CaPaEBR)ebr10611709 035 $a(CaONFJC)MIL395523 035 $a(FINmELB)ELB137061 035 $a(EXLCZ)992670000000259330 100 $a20180706d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe ethics of gender-specific disease /$fMary Ann G. Cutter 205 $a1st ed. 210 1$aNew York :$cRoutledge,$d2012. 215 $a1 online resource (164 p.) 225 1 $aRoutledge annals of bioethics ;$v11 225 0$aRoutledge annals of bioethics ;$v11 300 $aDescription based upon print version of record. 311 08$a0-415-50997-1 320 $aIncludes bibliographical references and index. 327 $aBackground -- Gender-specific disease: descriptive analysis -- Gender-specific disease: prescriptive analysis -- Gender-specific disease: contextual analysis -- An integrative approach to gender-specific disease -- Rethinking gender-specific disease nomenclature and taxonomies -- Toward an integrative bioethics -- Integrative bioethics and assessing gender-specific disease -- Implications for health care for men, children, and members of the lgbt communities -- Some lessons and challenges -- Concluding reflections. 330 $aOur understanding of gender carries significant bioethical implications. An errant account of gender-specific disease can lead to overgeneralizations, undergeneralizations, and misdiagnoses. It can also lead to problems in the structure of health-care delivery, the creation of policy, and the development of clinical curricula. In this volume, Cutter argues that gender-specific disease and related bioethical discourses are philosophically integrative. Gender-specific disease is integrative because the descriptive roles of gender, disease, and their relation are inextricably tie 410 0$aRoutledge Annals of Bioethics 606 $aMedical ethics 606 $aSex factors in disease 606 $aHealth$xSex differences 615 0$aMedical ethics. 615 0$aSex factors in disease. 615 0$aHealth$xSex differences. 676 $a174.2/969 700 $aCutter$b Mary Ann Gardell.$01102867 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910973505503321 996 $aThe ethics of gender-specific disease$94487533 997 $aUNINA